Collaborative Deprescribing of Proton Pump Inhibitors in Older Adults: Evidence and Practice скачать в хорошем качестве

Collaborative Deprescribing of Proton Pump Inhibitors in Older Adults: Evidence and Practice

This session was hosted by the Portuguese Deprescribing Network. Presenter: Dr António Teixeira Rodrigues (PharmD, PhD) has expertise in pharmacoepidemiology, public health, and health economics. He serves as Invited Assistant Professor at the School of Medicine, University of Minho, and as Director of the Centre for Health Evaluation and Research (CEFAR). He has collaborated with national and international institutions including iBiMED – Institute of Biomedicine, University of Aveiro; the Health Economics Unit at the University of Birmingham; and ISAMB – Instituto de Saúde Ambiental, Faculty of Medicine, University of Lisbon. Description: This session explores the design and implementation of the C-SENIoR pragmatic non-randomised controlled trial, a collaborative deprescribing model involving community pharmacists and general practitioners (GPs) to optimise the use of proton pump inhibitors (PPIs) in older adults. It focuses on communication strategies, workflow integration, and real-world challenges of translating evidence-based deprescribing practices into routine primary care. Learning objectives: Describe the components and rationale of a pharmacist–GP collaborative approach in deprescribing PPIs. Identify key communication and coordination mechanisms that support sustained interprofessional deprescribing initiatives. Critically appraise the feasibility and scalability of deprescribing models within existing primary care frameworks. For more information, visit: deprescribingnetwork.ca/journal-club